Table 4. Predictive value of combined ΔNLR and ΔSUV for pCR.

From: Good prediction of treatment responses to neoadjuvant chemoradiotherapy for esophageal cancer based on preoperative inflammatory status and tumor glucose metabolism

 

pCRpCR

Non-pCR

ΔNLR < 3 & ΔSUV ratio > 58% (N = 46)

39 (84.8%)

 

ΔNLR > 3 & ΔSUV ratio < 58% (N = 29)

 

26 (89.7%)

  1. pCR pathological complete response, ΔNLR the change of neutrophil–lymphocyte ratio before and after concurrent chemoradiotherapy, ΔSUV ratio the change of maximum standardized uptake value of the esophageal tumor before and after concurrent chemoradiotherapy to pre-chemotherapy.
Back to article page